Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MedTech

New MedTech Funding To Predict Diseases And Make Treatments Available To UK Patients

The UK government has awarded medtech funding to eight UK medtech companies which are developing pathbreaking tests and AI detection tools for faster treatment of life-threatening diseases, reducing the burden of NHS.

International Business Times UK

Stock Market Continues To Rally; ASML, Netflix, Tesla, Intel Are Big Earnings Movers: Weekly Review

The market rally continued amid near-perfect economic data. ASML and Netflix were earning winners. Tesla and Intel dived on guidance.

Investors Business Daily

J&J Flashes A Sell Signal Despite A MedTech Beat That Bodes Well For Its Rivals

Johnson & Johnson beat fourth-quarter expectations Tuesday, helped by strength from its medtech segment. But JNJ stock toppled.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Johnson & Johnson (JNJ): Analyzing Signals Before Quarterly Earnings

Pharmaceutical powerhouse Johnson & Johnson (JNJ) is proactively driving innovation throughout the healthcare spectrum, thanks to its strong focus on innovative medicines and MedTech solutions. However, with the company’s fiscal fourth-quarter earnings on the horizon, could the stock be a wise portfolio addition? Keep reading to find out….

StockNews.com

2 Dividend Kings Yielding Around 3% to Grab Now

High yields aren't the only reason to buy shares of dividend-paying stocks. For investors seeking quality dividend stocks for passive income, here's a look at two companies with long track records of raising shareholder payouts.

Barchart

His dad worked on the factory floor at Johnson & Johnson. Now he’s the CFO

Joe Wolk, with J&J for over 25 years, talks about his path and the company's focus on innovation.

Fortune

Should You Invest in Johnson & Johnson (JNJ) Following Q3 Results

Johnson & Johnson’s (JNJ) third-quarter results impressed investors, as its earnings and revenue beat Wall Street estimates. Should investors consider investing in the stock following the solid third-quarter results? Read on to learn my view….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

This J&J exec sold Tylenol and Listerine. Now she runs its $27B medtech business

Ashley McEvoy pivoted from over-the-counter products to medical devices.

Fortune

Future Fortune 500 CEOs: 11 up-and-comers that leadership experts see as generational standout bosses

Fortune has identified 11 CEO stars in the making—many of them already in the C-suite, and all potential large-company CEOs.

Fortune

PCR tests clinics to close on Friday, despite 'enough demand'

PCR testing in December 2021 and January 2022 was "armageddon".

Newcastle Herald

3 Large-Cap Pharma Stocks to Protect Your Portfolio Through 2023

The worst banking crisis since 2008 could not stop the Fed from raising the benchmark interest rate. The possibility of further policy tightening and strict lending standards for banks might push the economy into a recession this year. Therefore, investing in large-cap pharma stocks Johnson & Johnson (JNJ), Merck &…

StockNews.com

4 Best Pharma Stocks to Buy for the Long Haul

With the persistent rise in lifestyle diseases, the pharmaceutical industry is well poised for strong growth in the long term. Also, with the Fed likely to keep increasing the interest rates, the economy is likely to enter a recession, making pharma stocks attractive investment options. Therefore, investors could look to…

StockNews.com

3 Large-Cap Stocks You Can Buy for Under $200

The recent financial turmoil from several bank failures, the Fed’s persistent hawkish stance to battle stubborn inflation, and renewed recession worries have kept the stock market highly volatile lately. Amid this backdrop, investors could consider buying fundamentally sound, large-cap stocks Taiwan Semiconductor (TSM), Johnson & Johnson (JNJ), and Merck (MRK),…

StockNews.com

Want to Retire a Millionaire? 2 Stocks to Buy Now

The recent bank failures have increased the likelihood of a recession, with many economists increasing the odds of an economic slump in the next 12 months. Amid this backdrop, investors could buy fundamentally strong stocks, Johnson & Johnson (JNJ) and Pfizer (PFE), which could help retire a millionaire. Read on.

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Hot Stocks You Don't Want to Miss out on Right Now

The Silicon Valley Bank crisis will likely deter the Fed from raising interest rates by the expected 50 basis points next week. However, since the market is expected to remain highly volatile, it could be wise to invest in fundamentally strong stocks Johnson & Johnson (JNJ), Walmart (WMT), and General…

StockNews.com

3 Powerhouse Stocks to Buy in 2023

As the Fed is expected to raise interest rates higher than expected, the revived recession fears will keep the stock market under pressure in the upcoming months. Thus, it could be wise to scoop up shares of high-quality businesses, such as Johnson & Johnson (JNJ), Humana Inc. (HUM), and AutoZone,…

StockNews.com

3 Hot Dividend Stocks to Buy Now and Hold Forever

Due to a barrage of strong macroeconomic data, the Federal Reserve has expressed the need to keep interest rates elevated. This is expected to keep the market volatile. Amid this backdrop, it might be wise to buy fundamentally strong dividend stocks Johnson & Johnson (JNJ), Novartis (NVS), and ARC Document…

StockNews.com

3 Surefire Stocks You Can Buy Right Now

With higher-than-expected job gain and inflation, concerns about the Fed’s tight monetary policy pushing the economy into a recession still loom large. Therefore, investors could look to buy fundamentally strong and profitable stocks, Johnson & Johnson (JNJ), Canon (CAJ), and Forrester Research (FORR). Keep reading….

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Reliable Stocks That Could Help You Make Money in 2023

The stock market witnessed a decent rally in January, with cooling inflationary pressures reducing recession fears. However, the Fed’s attempts to bring inflation down to its 2% target could hurt economic growth. Hence, it could be wise to invest in shares of Johnson & Johnson (JNJ), Novartis (NVS), and LCNB…

StockNews.com

3 Stocks Every Smart Investor Should Own in 2023

With a recession expected this year due to the Fed’s hawkish stance, investors could look to buy fundamentally strong dividend-paying stocks Johnson & Johnson (JNJ), Kroger (KR), and Bluegreen Vacations Holding (BVH). Keep reading….

StockNews.com

Buy These 2 Stocks Now if You're Over the Age of 50

With concerns of a recession weighing heavily on investors’ decisions, well-reputed companies paying stable dividends could be smart investments for investors over 50. Therefore, it might be wise for investors to buy fundamentally strong stocks like Johnson & Johnson (JNJ) and Coca-Cola (KO). Read more….

StockNews.com

3 Stocks to Help Stabilize Your Portfolio in 2023

With interest rates expected to increase throughout this year, the stock market will likely remain under pressure. Amid the anticipated volatility in the stock market this year, investors may consider investing in stable and dividend-paying stocks Johnson & Johnson (JNJ), The Procter & Gamble Company (PG), and AptarGroup (ATR) to…

StockNews.com

3 Must Have Pharma Stocks in January 2023

Rising rates of chronic diseases, an aging population, and increasing healthcare spending should drive the pharma industry’s growth in the upcoming years. Moreover, pharma companies perform steadily regardless of economic conditions due to the inelastic demand for their products. Therefore, it could be wise to invest in fundamentally strong pharma…

StockNews.com

The 3 Safest Stocks to Buy in the Market Now

Along with an interest rate hike of 50 bps at the FOMC meeting last week, the Fed officials signaled to continue raising rates through next year, with no expectations to cut rates until 2024. The Fed’s hawkish stance and rising recessionary fears have dampened investor sentiment lately. Given the backdrop,…

StockNews.com

3 Stocks to Buy That Could Make You a Millionaire in the Long Term

Yesterday’s retail sales report showed that consumers pulled back on spending last month, raising fears of a recession. Moreover, the Fed signaled to keep raising rates more through the following year. Given an uncertain market backdrop, investors should buy fundamentally sound and dividend-paying stocks Johnson (JNJ), Coca-Cola (KO), and Cardinal…

1 2 3

People

Jerome Powell

3,168 stories

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.